Dipeptidyl peptidase-4 inhibitors and risk of heart failure in type 2 diabetes: systematic review and meta-analysis of randomised and observational studies

CORC > 兰州大学 > 兰州大学 > 第二临床医学院 > 期刊论文

	Dipeptidyl peptidase-4 inhibitors and risk of heart failure in type 2 diabetes: systematic review and meta-analysis of randomised and observational studies
	Li, L; Li, SY; Deng, K; Liu, JL; Vandvik, PO; Zhao, PJ; Zhang, LH; Shen, JT; Bala, MM; Sohani, ZN
刊名	BMJ-BRITISH MEDICAL JOURNAL
	2016-02-17
卷号	352
ISSN号	1756-1833
通讯作者	Sun, X (reprint author), Sichuan Univ, West China Hosp, Chinese Evidence Based Med Ctr, Chengdu 610041, Sichuan, Peoples R China.
学科主题	General & Internal Medicine
收录类别	SCIE ; PUBMED ; MEDLINE ; ESI
出版地	LONDON
语种	英语
WOS记录号	WOS:000370727700007
内容类型	期刊论文
源URL	[http://ir.lzu.edu.cn/handle/262010/179421]
专题	第二临床医学院_期刊论文
推荐引用方式 GB/T 7714	Li, L,Li, SY,Deng, K,et al. Dipeptidyl peptidase-4 inhibitors and risk of heart failure in type 2 diabetes: systematic review and meta-analysis of randomised and observational studies[J]. BMJ-BRITISH MEDICAL JOURNAL,2016,352.
APA	Li, L.,Li, SY.,Deng, K.,Liu, JL.,Vandvik, PO.,...&Sun, X.(2016).Dipeptidyl peptidase-4 inhibitors and risk of heart failure in type 2 diabetes: systematic review and meta-analysis of randomised and observational studies.BMJ-BRITISH MEDICAL JOURNAL,352.
MLA	Li, L,et al."Dipeptidyl peptidase-4 inhibitors and risk of heart failure in type 2 diabetes: systematic review and meta-analysis of randomised and observational studies".BMJ-BRITISH MEDICAL JOURNAL 352(2016).